HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thalidomide reduces vascular density in granulation tissue of subcutaneously implanted polyvinyl alcohol sponges in guinea pigs.

Abstract
The efficacy of thalidomide in the treatment of erythema nodosum leprosum is a well established fact; there is also accumulating evidence of its therapeutic value in a number of other inflammatory and immune-mediated conditions. In addition, thalidomide has been shown to be an inhibitor of angiogenesis induced by basic fibroblast growth factor (bFGF). Nevertheless, its mechanism of action remains speculative. Using guinea pigs, orally administered thalidomide significantly enhanced the response of multinucleated foreign body giant cells (p<0.05) in subcutaneously implanted polyvinyl alcohol sponges. Furthermore, the drug exerted a dual effect in that it reduced vascular density (p<0.05), which was not abolished by recombinant human bFGF, and at the same time amplified the granulomatous response with and without bFGF (p<0.05 and p<0.01, respectively). The results of our experiments represent a further step toward understanding the mechanism of action of thalidomide, with implications for its potential use in wound healing and scar formation as well as in the control of tumorigenesis.
AuthorsR Or, R Feferman, S Shoshan
JournalExperimental hematology (Exp Hematol) Vol. 26 Issue 3 Pg. 217-21 (Mar 1998) ISSN: 0301-472X [Print] Netherlands
PMID9502617 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Thalidomide
  • Polyvinyl Alcohol
  • DNA
  • Hydroxyproline
Topics
  • Animals
  • Cricetinae
  • DNA (metabolism)
  • Foreign-Body Reaction (prevention & control)
  • Granuloma (pathology)
  • Hydroxyproline (metabolism)
  • Male
  • Neovascularization, Pathologic (prevention & control)
  • Polyvinyl Alcohol
  • Porifera
  • Thalidomide (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: